Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Endo Health Solutions (Nasdaq: ENDP) is trading at unusually high volume Monday with five million shares changing hands. It is currently at two times its average daily volume and trading down $1.50 (-4.3%) at $33.47 as of 10:41 a.m. ET.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Endo Health has a market cap of $4.14 billion and is part of the health care sector and drugs industry. Shares are up 40.8% year to date as of the close of trading on Friday. Endo Health Solutions Inc. provides specialty healthcare solutions in the United States and internationally. TheStreet Ratings rates Endo Health as a hold. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk, disappointing return on equity and weak operating cash flow. You can view the full Endo Health Ratings Report. See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center. Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.